PSQ Holdings, Inc. 8-K
Research Summary
AI-generated summary
PSQ Holdings Reports Preliminary 2025 Results; NYSE Notice of Non-Compliance
What Happened
PSQ Holdings, Inc. (PSQH) filed an 8-K on February 17, 2026, furnishing a press release with its preliminary financial results for the quarter and year ended December 31, 2025. The filing also discloses that on February 10, 2026 the New York Stock Exchange notified the company it is not in compliance with NYSE Rules 802.01B (minimum market capitalization and stockholders’ equity) and 802.01C (minimum average closing price). The notice is not an immediate delisting; the company has outlined steps it intends to take to attempt to regain compliance.
Key Details
- Press releases reporting preliminary 2025 financial results and the NYSE notice were furnished as Exhibits 99.1 and 99.2 on Feb 17, 2026.
- NYSE non-compliance cited: Rule 802.01B (minimum total market cap and stockholders’ equity) and Rule 802.01C (minimum average closing price).
- Company intends to notify the NYSE within 10 business days of its intent to submit a business plan for 802.01B and its intent to cure 802.01C.
- The company will respond within 45 days with a business plan showing compliance with Rule 802.01B within 18 months if accepted; if accepted, PSQH would be subject to quarterly monitoring.
- For Rule 802.01C, PSQH can regain compliance during the six-month cure period if, on the last trading day of any month in the cure period, the closing share price and the 30-trading-day average closing price are both at least $1.00.
Why It Matters
The filing combines operational news (preliminary 2025 results) with a regulatory risk that could affect trading and investor value: an NYSE notice of non-compliance can lead to increased volatility and, if unresolved, possible suspension and delisting. Investors should watch for the company’s upcoming business plan, any updates to the preliminary financials, and share-price movement toward the $1.00 cure threshold. The filing also contains forward-looking statements and cautions that outcomes are uncertain.